Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-027433
Filing Date
2012-05-03
Accepted
2012-05-03 16:53:37
Documents
1
Period of Report
2012-05-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd343825.html 4  
1 FORM 4 rrd343825.xml 4 10310
  Complete submission text file 0001181431-12-027433.txt   11659
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1300 SEAPORT BOULEVARD REDWOOD CITY CA 94063
Business Address
OSTRACH MICHAEL S (Reporting) CIK: 0001226066 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34207 | Film No.: 12810485